DYN vs KEY · $1.19B cap vs P/E 13, rev $7.51B
Dyne Therapeutics Inc (DYN) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
DYN does not have a complete income-statement cache yet.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
DYN currently screens at market cap $1.19B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the DYN and KEY stock pages for the full models.
Not investment advice.